Torrey Pines Clinical Consltng is categorized under Business Consultants in San Diego, CA and active since 2010.
Torrey Pines Clinical Consltng was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 6219991 by the NAICS.
If you are seeking more information, feel free to contact Guy Hagen, Owner at the company’s single location by writing to 5537 Caminito Vista Lujo, San Diego, California CA 92130 or by phoning (858) 720-1897. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Torrey Pines Clinical Consltng |
Contact Person: | Guy Hagen, Owner |
Address: | 5537 Caminito Vista Lujo, San Diego, California 92130 |
Phone Number: | (858) 720-1897 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Business Consultants |
SIC Code: | 8748 |
NAICS Code: | 6219991 |
Share This Business: |
Torrey Pines Clinical Consltng was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 6219991. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Guy Hagen, Owner for inquiries that concern Torrey Pines Clinical Consltng by calling the company number (858) 720-1897, as your correspondence is most welcome. Additionally, the physical location of the single location of Torrey Pines Clinical Consltng can be found at the coordinates 32.946768,-117.199804 as well as the street address 5537 Caminito Vista Lujo in San Diego, California 92130.
For its online presence, you may visit Torrey Pines Clinical Consltng’s website at and engage with its social media outlets through on Twitter and on Facebook.